Original publications

Manuscripts in preparation

Books and Chapters

Posters and Oral Presentations

Google Scholar Profile

Original publications

  1. Alvarez-Gonzalez C, Duggleby R, Vagaska B, Querol S, Gomez SG, Ferretti P, Madrigal A. (2013) Cord Blood Lin−CD45− Embryonic-Like Stem Cells Are a Heterogeneous Population That Lack Self-Renewal Capacity. PLoS ONE 8(6): e67968. doi:10.1371/journal.pone.0067968. (http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067968)
  2. New SE*, Alvarez-Gonzalez C*, Vagaska B*, Gomez SG, Bulstrode NW, Madrigal A, Ferretti P. A matter of identity — Phenotype and differentiation potential of human somatic stem cells. Stem Cell Res. 2015 Apr 25;15(1):1-13. doi: 10.1016/j.scr.2015.04.003. PMID: 25957945 (http://www.sciencedirect.com/science/article/pii/S1873506115000458) *Joint first authors, shared contribution
  3. Vagaska B, New S.E.P, Alvarez-Gonzalez C, D’Acquisto F, Gomez S.G, Bulstrode N.W, Madrigal A, Ferretti P. (2016) MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ–independent fashion and during development. Scientific Reports 6, Article number: 24251. doi:10.1038/srep24251. (http://www.nature.com/articles/srep24251)
  4. Alvarez-Gonzalez C, Allen-Philbey K, Mathews J et al. Treating multiple sclerosis with generic cladribine. Mult Scler J 2016; 22: (S3) 604-605.
  5. C Alvarez-Gonzalez, K Allen-Philbey, J Mathews, BP Turner, D Baker, S Gnanapavan, M Marta, G Giovannoni and K Schmierer, TREATING MULTIPLE SCLEROSIS WITH CLADRIBINE. J Neurol Neurosurg Psychiatry 2016 87:e1. doi:10.1136/jnnp-2016-315106.121
  6. Alvarez-Gonzalez, C., Adams, A., Mathews, J., Turner, B. P., Giovannoni, G., Baker, D. and Schmierer, K. (2017), Cladribine to treat disease exacerbation after fingolimod discontinuation in progressive multiple sclerosis. Ann Clin Transl Neurol. doi:10.1002/acn3.410
  7. David Baker PhD, Samuel Spencer Herrod BSc, Cesar Alvarez Gonzalez PhD, Christo Albor PhD, Klaus Schmierer PhD. (2017) Both cladribine and alemtuzumab may affect multiple sclerosis via B cell depletion. Neurol Neuroimmunol Neuroinflamm July 2017 vol. 4 no. 4 e360. doi: http:/ / dx. doi. org/ 10. 1212/ NXI. 0000000000000360
  8. Baker D, Herrod SS, Alvarez-Gonzalez C, Giovannoni G, Schmierer K. Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab. JAMA Neurol. Published online June 12, 2017. doi:10.1001/jamaneurol.2017.0676
  9. Klaus Schmierer, Samuel Herrod, Cesar Alvarez-Gonzalez and David Baker. Cladribine versus Alemtuzumab: efficacy and autoimmunity in multiple sclerosis induction treatment. Neurology April 18, 2017 vol. 88 no. 16 Supplement P6.383.
  10. Campollo O, Sheikhattari P, Alvarez C, Toro-Guerrero J, Sanchez Avila H, Wagner FA. Factors associated with tobacco, alcohol, and other drug use among youth living in West Central Mexico. World J Psychiatr 2018; 8(1): 33-42. doi: 10.5498/wjp.v8.i1.33
  11. Mao Z, Alvarez-Gonzalez C, Albor C, Soon D, Turner BP, Mathews J3, Giovannoni G, Baker D, Schmierer K. Cladribine: off-label disease modification for people with multiple sclerosis in resource poor settings? Multiple Sclerosis Journal – Experimental, Translational and Clinical. 2018;4(2):2055217318783767. doi:10.1177/2055217318783767.
  12. Mao Z, Alvarez-Gonzalez C, Turner BP, Marta M, Gnanapavan S, Espasandin M, Allen-Philbey K, Mathews J, Giovannoni G, Baker D, Schmierer K. Treating the ineligible: Disease modification in people with multiple sclerosis beyond NHS England commissioning policies Multiple Sclerosis and Related Disorders 2018, Volume 27, 247-253, https://doi.org/10.1016/j.msard.2018.11.001.
  13. M Schroeder-Castagno, C Alvarez-Gonzalez, A Papadopoulou, I Hinz, N Borisow, K Ruprecht, J Bellmann-Strobl, M Scheel, F Paul, C Infante-Duarte. Impaired neutrophil death in AQP4-IgG-seropositive NMO patients. MULTIPLE SCLEROSIS JOURNAL 2018, 24 187-188. SAGE PUBLICATIONS LTD.
  14. Schwichtenberg, S. C., Wisgalla, A., Schroeder-Castagno, M., Alvarez-González, C., Schlickeiser, S., Siebert, N., Bellmann-Strobl, J., Wernecke, K.-D., Paul, F., Dörr, J. & Infante-Duarte, C. Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells. Neurotherapeutics 1–15 (2021). doi:10.1007/s13311-021-01078-7
  15. Allen-Philbey, K., Trane, S. D., Mao, Z., Álvarez-González, C., Mathews, J., MacDougall, A., Stennett, A., Zhou, X., Yildiz, O., Adams, A., Bianchi, L., Blain, C., Chapman, C., Chung, K., Constantinescu, C. S., Dalton, C., Farrell, R. A., Fisniku, L., Ford, H., Gran, B., Hobart, J., Khaleeli, Z., Mattoscio, M., Pavitt, S., Pearson, O., Peruzzotti-Jametti, L., Scalfari, A., Sharrack, B., Silber, E., Tallantyre, E. C., Webb, S., Turner, B. P., Marta, M., Gnanapavan, S., Juliusson, G., Giovannoni, G., Baker, D. & Schmierer, K. Subcutaneous cladribine to treat multiple sclerosis: experience in 208 patients. Ther Adv Neurol Diso 14, 175628642110576 (2021).
  16. Maria Schroeder-Castagno, Alba Del Rio-Serrato, Andreas Wilhelm, Silvina Romero-Suárez, Patrick Schindler, Cesar Alvarez-González, Ankelien-Solveig Duchow, Judith Bellmann-Strobl, Klemens Ruprecht, Maria Hastermann, Gerald Grütz, Brigitte Wildemann, Sven Jarius, Tanja Schmitz-Hübsch, Friedemann Paul & Carmen Infante-Duarte.  Impaired response of blood neutrophils to cell-death stimulus differentiates AQP4-IgG-seropositive NMOSD from MOGAD. J Neuroinflammation 19, 239 (2022). https://doi.org/10.1186/s12974-022-02600-0.
  17. Álvarez-González C. Meet the Editor: César Alvarez González. Arch Neurocien [Internet]. 2022 Oct. 15 [cited 2023 Aug. 19];1(Inpress). Available from: https://archivosdeneurociencias.org/index.php/ADN/article/view/418
  18. Cerdá-Fuertes, Nuria; Stoessel, Marc; Mickeliunas, Gintaras; Pless, Silvan; Cagol, Alessandro; Barakovic, Muhamed; Maceski, Aleksandra; Alvarez-González, César; D’Souza, Marcus; Schaedelin, Sabine; Benkert, Pascal; Calabrese, Pasquale; Gugleta, Konstantin; Derfuss, Tobias; Sprenger, Till; Granziera, Cristina; Naegelin, Yvonne; Kappos, Ludwig; Kuhle, Jens; Papadopoulou, Athina. Optical coherence tomography versus other biomarkers: Associations with physical and cognitive disability in multiple sclerosis. Multiple Sclerosis Journal. 2023;0(0). doi:10.1177/13524585231198760

Manuscripts in preparation | Preprints

Books and Chapters

  1. Cesar Alvarez-Gonzalez, Alejandro Madrigal (2011). Chapter 16: Regenerative Medicine. Parkinson’s disease. Mexican Clinics of Neurology. Collection: Mexican Academy of Neurology 1/2011. Editors: Dr. Gabriel Neri Nani and Dr Carlos Cuevas García. Publishing: PyDESA. ISBN: 978-607-8151-04-2. (Spanish).
  2. Cesar Alvarez-Gonzalez (2017), Capítulo 10: El potencial de las células troncales en medicina y neurología. Libro: Entendiendo el Alzheimer: una guía para el cuidador. Editores: Dr. Jorge Efraín Salazar Ceballos, Dra. María del Carmen Frías Castañeda, Dr César Álvarez González. Minaya Editorial. ISBN: 978-1-5323-7493-7. (Spanish).
  3. Cesar Alvarez-Gonzalez (2019), Capítulo 10.1.1: NEUROLOGÍA REGENERATIVA EN LA ENFERMEDAD DE PARKINSON. Libro: Entendiendo al paciente con Enfermedad de Parkinson. Editores: Dr. Jorge Efraín Salazar Ceballos, Dra. María del Carmen Frías Castañeda, Dr César Álvarez González, Dr Carlos Cerdeña Arredondo. Minaya Editorial. (Spanish).

Posters and Oral Presentations

  1. Cesar Alvarez-Gonzalez. Clinical and Biomedical Complexity. Speaker at III Congreso Internacional de Medicina Anáhuac. Universidad Anáhuac Querétaro. Nov. 3, 2022. Querétaro, Mexico. (Spanish).
  2. Cesar Alvarez Gonzalez. Immune-reconstitution therapies in Multiple Sclerosis. Speaker at 5° SIMPOSIO TÓPICOS SELECTOS EN NEUROGENÉTICA and Instituto Nacional de Neurología y Neurocirugía. July 2019. Mexico City, Mexico. (Spanish).
  3. Cesar Alvarez-Gonzalez. Clinical Neuroimmunology for non-neurologists. Speaker at X Congreso Internacional de Medicina General y Familiar. June 2019. Cancun, Mexico. (Spanish).
  4. Cesar Alvarez-Gonzalez. Multiple Sclerosis for non-neurologists. Speaker at X Congreso Internacional de Medicina General y Familiar. June 2019. Cancun, Mexico. (Spanish).
  5. Cesar Alvarez-Gonzalez. Stem Cells in medicine and neurology: hope or fraud?. Speaker at X Congreso Internacional de Medicina General y Familiar. June 2019. Cancun, Mexico. (Spanish).
  6. Cesar Alvarez-Gonzalez. Stem Cells and Regenerative Neurology: myths and realities. Speaker at Hospital General de Cancun, “Dr. Jesus Kumate Rodriguez”. January 2019. Cancun, Mexico. (Spanish).
  7. Cesar Alvarez Gonzalez. Immune reconstitution therapy for MS: resetting the immune system. Speaker at UMAE Centro Médico Nacional de Occidente, IMSS. 2019. Guadalajara, Mexico. (Spanish).
  8. Klaus Schmierer, Samuel Herrod, Cesar Alvarez-Gonzalez and David Baker. Cladribine versus Alemtuzumab: efficacy and autoimmunity in multiple sclerosis induction treatment. Poster AAN Annual Meeting, April 2017, Boston, USA. (English)
  9. César Álvarez González. Stem Cells and Regenerative Neurology: myths and realities. Speaker at Hospital Regional ISSTE Mérida “Elvia Carrillo Puerto”. Mérida, Yucatán, México. April 19th, 2017. (Spanish)
  10. Alvarez-Gonzalez C, Allen-Philbey K, Mathews J, Turner BP, Baker D, Gnanapavan S, Marta M, Giovannoni G, Schmierer K. “Treating multiple sclerosis with generic cladribine”. Poster at 32nd Congress of the European Committee for treatment and research in Multiple Sclerosis (ECTRIMS). London, UK, September 2016 (English).
  11. Schmierer K, Herrod SS, Alvarez-Gonzalez C, Marta M, Baker D. Lymphocyte dynamics and (auto) immunity in multiple sclerosis induction treatment: Clues from phase III trial data of Cladribine compared to Alemtuzumab. 13th ISNI Congress, Jerusalem (Israel), 26-29 Sep 2016. (English)
  12. Alvarez-Gonzalez C, Allen-Philbey K, Mathews J, Turner BP, Baker D, Gnanapavan S, Marta M, Giovannoni G, Schmierer K. “Treating multiple sclerosis with Cladribine”. Poster at the ABN Annual Meeting. Brighton, UK, May 2016 (English).
  13. Cesar Alvarez-Gonzalez, Richard Duggleby, Barbora Vagaska, Sergio Querol, Susana G Gomez, Patrizia Ferretti, and Alejandro Madrigal. “Cord blood embryonic-like stem cells are a heterogeneous population that lack self-renew capacity”. Poster at the 39th Annual Meeting of the European Group for Blood and Marrow Transplantation. London, UK. April 2013. (English)
  14. New SEP, Alvarez C, Guasti L, Bulstrode NW, Madrigal A, Ferretti P. “Towards modeling of childhood neurological disorders using human stem cells derived from paediatric adipose tissue and umbilical cord matrix”. Poster at NC3Rs Meeting 2013, London, UK. (English)
  15. New SEP, Alvarez C, Guasti L, Bulstrode NW, Madrigal A, Ferretti P. “Neural differentiation potential of human stem cells derived from paediatric adipose tissue and umbilical cord matrix”. Poster at UCL Neuroscience Symposium 2013. London, UK. (English)
  16. Alvarez GC, Carbajal RA, Garcia L.“An isolated form of spinal subarachnoid cysticercosis” poster presentation at the 19th Congress of Medical Residencies. Specialty Hospital, National Medical Center “Century XXI”, Mexican Institute of Social Security, México City, January 2007. (Spanish)
  17. Alvarez GC, Aguilar CS. “Neurophysiological pattern in patients with Guillain- Barre syndrome” poster presentation at the 19th Congress of Medical Residencies. Specialty Hospital, National Medical Center “Century XXI”, Mexican Institute of Social Security, México City, January 2007. (Spanish)
  18. Bañales VJ, Arechiga RN, Alvarez GC. “Creutzfeld-Jakob disease: a brief report” poster presentation at the 19th Congress of Medical Residencies. Specialty Hospital, National Medical Center “Century XXI”, Mexican Institute of Social Security, México City, January 2007. (Spanish)
  19. Andrade RR, Alvarez GC. “Neuroleptic Malignant syndrome: a brief report” poster presentation at the 19th Congress of Medical Residencies from Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, México, D.F., January 2007.
  20. Bañales VJ, García RJ, Aguilar CS, Alvarez GC. “Stiff-person syndrome with anti- GAD antibodies positive and improvement with human immunoglobulin” poster presentation at the 19th Congress of Medical Residencies. Specialty Hospital, National Medical Center “Century XXI”, Mexican Institute of Social Security, México City, January 2007. (Spanish)
  21. Alvarez GC. “Alzheimer and Parkinson Diseases” speaker at “caregiver at the end of life workshop”, General Regional Hospital 110, Mexican Institute of Social Security, Guadalajara, México, May 2007. (Spanish)
  22. Alvarez C, Favila J. “Affective comorbidity and treatment among patients with chronic diseases in a psychotherapeutic group from the HE CMN S XXI” poster presentation at the 18th Congress of Medical Residencies. Specialty Hospital, National Medical Center “Century XXI”, Mexican Institute of Social Security, Mexico City, October 2006. (Spanish)
  23. Trainer at “Botulinum Toxin A Workshop”; México City, October 2006. (Spanish)
  24. Alvarez GC, Aguilar CS. “Neurophysiological pattern in patients with Guillain-Barre syndrome” poster presentation at the 17th Scientific Research Week,University of Guadalajara, Guadalajara, México, November 2006. (Spanish)
  25. Alvarez C, Favila J,. “Affective comorbidity and treatment among patients with chronic diseases in a psychotherapeutic group from the HE CMN S XXI” posterpresentation at the 17th Scientific Research Week, University of Guadalajara,Guadalajara, México, November 2006. (Spanish)
  26. Alvarez GC. “Hemispheric specialisation and localisation of functions” speakerat the 30th Annual Meeting of the Mexican Academy of Neurology, Merida,México, November 2006. (Spanish)
  27. Alvarez GC, Carbajal RA, Garcia L. “An isolated form of spinal subarachnoidcysticercosis” poster presentation at the 30th Mexican Academy of Neurology Annual Meeting, Merida, México, November 2006. (Spanish)
  28. Alvarez C Favila J. “Affective comorbidity and treatment among patients with chronic diseases in a psychotherapeutic group from the HE CMN S XXI” poster presentation at the 30th Mexican Academy of Neurology Annual Meeting. Merida, México, November 2006. (Spanish)
  29. Andrade RR, Alvarez GC. “Neuroleptic Malignant syndrome: a brief report” poster presentation at the 30th Mexican Academy of Neurology Annual Meeting, Merida, México, November 2006. (Spanish)
  30. Bañales VJ, García RJ, Aguilar CS, Alvarez GC. “Stiff-person syndrome with anti- GAD antibodies positive and improvement with human immunoglobulin” poster presentation at 30th Mexican Academy of Neurology Annual Meeting, Merida, México, November 2006. (Spanish)
  31. Bañales VJ, Arechiga RN, Alvarez GC. “Creutzfeld-Jakob disease: a brief report” poster presentation at the 30th Mexican Academy of Neurology Annual Meeting, Merida, México, November 2006. (Spanish)
  32. Campollo, Octavio, Alvarez-Gonzalez C; Sanchez H.; Hernandez-Ruiz, G Toro- Guerrero, J. “Prevalence of alcohol, tobacco and drugs use in high school students in the Jalisco State, Mexico” poster presentation at the 2005 NIDA International Forum. Linking Drug Abuse and HIV/AIDS Research. Orlando, Florida, USA, June 2005. (English)
  33. Campollo O, Alvarez GC, Toro GJ, Montserrat CS, Robles LF, Sanchez H. “Prevalence and pattern of cigarette smoking among high school students” poster presentation at the Fifth International Forum of Alcoholism and Addictions Research, University of Guadalajara, Guadalajara, México, 2004. (Spanish)
  34. Campollo O, Alvarez C, Sanchez HA, Toro GJ. “Pattern of alcoholism in high school students” poster presentation at the 17th Congress of Medical Residencies and Third International Congress of Medical Specialties. Specialty Hospital, National Medical Center “Century XXI”, Mexican Institute of Social Security, Mexico City, October 2004. (Spanish)
  35. Canto V, Alvarez C, García J, Castrejon H. “Clinic case POEMS syndrome” poster presentation at the 17th Congress of Medical Residencies and Third International Congress of Medical Specialties. Specialty Hospital, National Medical Center “Century XXI”, Mexican Institute of Social Security, Mexico City, October 2004. (Spanish)
  36. Campollo RO, Alvarez GC, Toro GJ. “Pattern of alcoholism in high school students” poster presentation at the 28th Annual Meeting of the Mexican Academy of Neurology, Leon, México, October 2004. (Spanish)
  37. Alvarez C, Canto B, Castrejon H. “clinic case: POEMS syndrome” poster presentation at the 28th Mexican Academy of Neurology Annual Meeting, Leon, México, October 2004. (Spanish)
  38. Campollo O, Alvarez GC, Sanchez H, Toro GJ. “Pattern of alcoholism in high school students” poster presentation at the First Congress of Addictive Disorders of Iberoamerica, Compostela, Spain. February 2004. (Spanish)
  39. Campollo O, Alvarez GC, Sanchez HA, Toro GJ. “Pattern of alcoholism in high school students” speaker at the 4th International Forum of Addictions Research, University of Guadalajara, Guadalajara, México May 2003. (Spanish)
  40. Campollo O, Alvarez GC, Sanchez HA, Toro GJ. “Pattern of alcoholism in high school students” poster presentation at the National Congress of Gastroenterology. Mexican Association of Gastroenterology, Veracruz, México, November 2003. (Spanish)
  41. Alvarez G. Cesar MPSS; Toro G. Jaime A. MPSS; Campollo Rivas Octavio MD,PhD. “Prevention program of addictions based in the adequate use of leisure time of high school students from University of Guadalajara” poster presentation at the 13th National Scientific Research Week, University of Guadalajara, Guadalajara, Mexico, November 2002. (Spanish)
  42. Alvarez G. Cesar MPSS; Toro G. Jaime A. MPSS; Campollo Rivas Octavio MD/PhD. “Prevention program of addictions based in the adequate use of leisure time of high school students from University of Guadalajara” oral presentation at the 4th International Congress of Psychology (Psychology of Addictions in the XXI Century, Its Influence in the Human) University UNIVA, Guadalajara, México, November 2002. (Spanish).

Other publications

  • Cesar Alvarez-Gonzalez. Neurophysiological pattern in patients with Guillain- Barre syndrome. 2007. Thesis to obtain the specialist diploma. (Spanish)
  • Cesar Alvarez-Gonzalez, “Our aim: the academic excellence!” prologue for the congress abstracts book for the 19th Congress of Medical Residencies. Specialty Hospital, National Medical Center “Century XXI”, Mexican Institute of Social Security, Mexico City, January 2007. (Spanish)

Reach out and say 'Hello'

Contact

César Alvarez-González MD, PhD

Physician-Clinician-Scientist

Subscribe to the Blog

TUUKUL (Maya Yucateco): Thought, imagination; to think, ponder, reason.

Providing inspiration and stories for people’s one and only brain.

| Privacy Policy | Terms of Service

2024 © César Alvarez-González (NeuroWanderer)
Licensed doctor in Mexico